Recent Finacing
Recent Raise
Previse develops molecular diagnostic tests, starting with Esopredict™, to predict which Barrett’s esophagus patients are likely to progress to esophageal cancer.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Previse.
